- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04831333
Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis
Deep Learning-based System for Detection of AIDS-related Cytomegalovirus Retinitis in Ultra-Widefield Fundus Images
Ophthalmological screening for cytomegalovirus retinitis (CMVR) for HIV/AIDS patients is important. However, the manual screening with fundus imaging is laborious and subjective.
Deep learning (DL) system has been developed for the automated detection of various eye diseases with high accuracy and efficiency, including diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), papilledema, lattice degeneration and retinal breaks, from ocular fundus photographs. UWF imaging is a relatively new imaging modality for DL system but has also shown extraordinary talents in automatic retinal analysis With the press for routine CMVR screening in AIDS patients and the great capacity of DL system, the use of deep learning (DL) system to AIDS-related CMVR with Ultra-Widefield (UWF) fundus images is promising.
The investigators previously developed a DL system to detect AIDS-related CMVR. For further evaluating the applicability of the DL system, a prospective dataset is needed.
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100069
- Beijing Youan Hospital, Capital Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
The UWF images from HIV/AIDS patients.
Exclusion Criteria:
- The UWF images would be excluded if all three human graders gave different diagnosis.
- The UWF images with poor quality would be excluded.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Active CMVR
The UWF images of cytomegalovirus retinitis (CMVR) included various patterns: hemorrhagic necrotizing lesion, granular lesion, frosted branch angiitis, and optic neuropathy lesion.
Active CMVR lesion was defined as obvious opacity (mild, moderate, severe, very severe)
|
|
Inactive CMVR
Inactive CMVR lesion was defined as a lack of opacity or questionable/equivocal activity.
|
|
Non-CMVR
The non-CMVR images included normal retina and other retinopathies such as HIV-related microvascular retinopathy, diabetic retinopathy, retinal detachment, vitreous hemorrhage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluating the applicability of the DL system to identify AIDS-related CMVR
Time Frame: April 2021
|
The investigators compared the performance between two trained (senior and junior) retinal ophthalmologists with the DL system.
A senior retinal ophthalmologist and a junior retinal ophthalmologist were asked to independently screen the UWF images in the prospective dataset.
Accuracy, sensitivity and specificity were used to evaluate the performance.
|
April 2021
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Kui-Fang Du, Beijing Youan Hospital
- Study Director: Li Dong, Beijing Tongren Hospital
- Principal Investigator: Kai Zhang, Beijing Tongren Hospital
- Principal Investigator: Chao Chen, Beijing Youan Hospital
- Principal Investigator: Lian-Yong Xie, Beijing Youan Hospital
- Principal Investigator: Wen-Jun Kong, Beijing Youan Hospital
- Principal Investigator: Hong-Wei Dong, Beijing Youan Hospital
- Principal Investigator: He-Yan Li, Beijing Tongren Hospital
- Principal Investigator: Rui-Heng Zhang, Beijing Tongren Hospital
- Principal Investigator: Wen-Da Zhou, Beijing Tongren Hospital
- Principal Investigator: Hao-Tian Wu, Beijing Tongren Hospital
- Study Chair: Wen-Bin Wei, Beijing Tongren Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210331001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cytomegalovirus Retinitis
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; Baylor College of Medicine; University of California... and other collaboratorsCompletedHIV Infections | CMV Cytomegalovirus Retinitis
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
Ionis Pharmaceuticals, Inc.CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
National Institute of Allergy and Infectious Diseases...Hoffmann-La RocheCompletedGastrointestinal Diseases | HIV Infections | Cytomegalovirus RetinitisUnited States
-
Tianjin Medical UniversityRecruitingCytomegalovirus Retinitis | Ganciclovir Eye DropsChina
-
Astra USAUnknownHIV Infections | Cytomegalovirus RetinitisUnited States
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; Memorial Sloan Kettering Cancer Center; Baylor College... and other collaboratorsCompletedHIV Infections | Cytomegalovirus Retinitis
-
National Institute of Allergy and Infectious Diseases...Gilead SciencesCompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
National Institute of Allergy and Infectious Diseases...Completed